Dove Hypoallergenic Body Wash Class Action Lawsuit (2026)

Dove Sensitive Hypoallergenic Body Wash class action lawsuit 2026 d-Limonene fragrance allergen

Published: June 14, 2026

▼ Allegations Only · No Settlement Yet

This article describes a class action complaint. The statements below are unproven allegations. Conopco, Inc. has not been found liable, there is no certified class, and nothing to claim at this time. This page is informational and is not legal advice.

Status Complaint Filed — Early Stage

Filed May 8, 2026 N.D. Cal. · Case No. 3:26-cv-04286-SK

Product Dove Sensitive Hypoallergenic Body Wash Sold by Conopco, Inc., a Unilever subsidiary

Can I Claim? No — nothing to claim yet No settlement, no claim form. Watch this page for updates.

What Is This Lawsuit About?

A proposed class action filed on May 8, 2026 in the U.S. District Court for the Northern District of California alleges that Conopco, Inc. — the Unilever subsidiary behind the Dove brand — falsely markets its Dove Sensitive Hypoallergenic Body Wash as "hypoallergenic" when, according to the complaint, the product contains a known fragrance allergen.

The case is captioned Mills v. Conopco, Inc., No. 3:26-cv-04286-SK. It is brought on behalf of a proposed California class and a proposed nationwide class of consumers who bought the body wash. The complaint asserts claims for breach of express warranty, violations of California's Unfair Competition Law, False Advertising Law, and Consumers Legal Remedies Act, and unjust enrichment.

At this stage these are only allegations. Conopco has not responded to the merits, no class has been certified, and the court has not ruled on whether the "hypoallergenic" claim is misleading.

The Core Allegation: "Hypoallergenic" vs. d-Limonene

The complaint's central theory is straightforward. The named plaintiffs say they commissioned independent analytical testing of the body wash in April 2026 using headspace gas chromatography coupled with mass spectrometry (GC/MS), a laboratory method used to identify fragrance constituents. According to the complaint, that testing detected d-Limonene — a citrus-derived fragrance ingredient that the lawsuit describes as one of 26 fragrance allergens the FDA recognizes (citing European Commission research) as among those that most commonly cause allergic reactions from cosmetic products.

The complaint alleges that d-Limonene is not listed by name on the label, but is present as a component of the product's generic "fragrance" ingredient and is discoverable only through testing. The plaintiffs argue that intentionally including a recognized fragrance allergen directly contradicts a voluntary "hypoallergenic" claim, rendering it, in their words, false and misleading.

The suit frames "hypoallergenic" as communicating to a reasonable consumer that a product is formulated to reduce the likelihood of allergic reactions — including, at a minimum, by avoiding the intentional inclusion of known contact allergens. The complaint notes that the FDA has not defined the term "hypoallergenic" by regulation, but has acknowledged that manufacturers use it to suggest a product is less likely to cause allergic reactions than competing products.

What the Plaintiffs Say They Experienced

The complaint is brought by three California consumers who say they bought the body wash at retailers including Walmart, Target, and Grocery Outlet between roughly 2023 and 2025. Each says they read and relied on the "hypoallergenic" representation, understood it to mean the product was formulated to reduce allergic reactions and did not include known fragrance allergens, and would not have bought the product — or would have paid less — had they known what the testing allegedly showed.

The economic-injury theory here is a price-premium theory, not a personal-injury theory. The plaintiffs do not claim the body wash physically injured them. Instead, they allege they overpaid because the "hypoallergenic" label commanded a premium and they did not receive the product they believed they were buying.

Who Could Be Covered If a Class Is Certified?

The complaint proposes two classes:

A California class of all persons in California who purchased the product in California during the applicable class period, and a nationwide class of all persons who purchased the product in the United States during the applicable class period.

The complaint states the class period runs back as far as the statutes of limitation allow — generally three to four years before filing, depending on the claim. No class has been certified, so these definitions could narrow, expand, or change as the case proceeds. The lawsuit estimates the proposed classes include tens of thousands of purchasers.

What the Lawsuit Is Asking For

The complaint seeks class certification, restitution or disgorgement of profits, compensatory damages and statutory penalties where available, an injunction barring the allegedly deceptive labeling and requiring corrective advertising, attorneys' fees and costs, and a jury trial. The amount in controversy is alleged to exceed $5 million, the threshold for federal jurisdiction under the Class Action Fairness Act.

Is There a Settlement or a Claim Form?

No. This is a newly filed complaint in its earliest stage. There is no settlement, no settlement website, no settlement fund, and no claim form. No money is available, and there is nothing to sign up for right now.

If the case eventually settles or the plaintiffs prevail, a court-approved notice and claims process would be established at that point, and eligible buyers would be told who is included and how to file. Be cautious of any site claiming you can "file a Dove body wash claim" today — no legitimate claims process exists yet.

What Happens Next?

Conopco will likely respond to the complaint, often with a motion to dismiss testing the legal theory — for example, whether a reasonable consumer would read "hypoallergenic" to promise the absence of every recognized fragrance allergen, and whether the plaintiffs' testing supports their claims. If the case survives, the parties would move into discovery and a fight over class certification. Any of those stages can take many months to years. This page will be updated as the docket develops.

If you regularly buy products marketed as "sensitive" or "hypoallergenic," it is worth noting that the FDA does not enforce a fixed legal standard for the word, so its meaning can vary by manufacturer. Readers interested in how consumer-labeling cases work may also find our coverage of the Hawaiian Host macadamia nut labeling lawsuit and the Quest protein shake lead lawsuit useful background on how these claims are framed.

Complaint PDF

Download the Full Class Action Complaint (PDF)

Frequently Asked Questions

Is this a settlement? Can I file a claim?

No. This is a newly filed lawsuit, not a settlement. There is no settlement fund, no claim form, and no money available at this time. If the case later settles or the plaintiffs win, a claims process would be announced through the court.

What product does the Dove lawsuit target?

The complaint targets Dove Sensitive Hypoallergenic Body Wash, sold by Conopco, Inc., a subsidiary of Unilever. The suit focuses on the "hypoallergenic" claim on the product's packaging.

What does the lawsuit allege?

The complaint alleges that independent gas chromatography/mass spectrometry testing detected d-Limonene, one of 26 fragrance allergens recognized by the FDA, in the product. The plaintiffs argue that including a known fragrance allergen makes the "hypoallergenic" label false and misleading. The allegations are unproven.

Who could be covered by the proposed class?

The complaint proposes a California class of people who bought the product in California and a nationwide class of people who bought it in the United States during the applicable class period. No class has been certified, so the definition could change.

What is d-Limonene?

d-Limonene is a citrus-derived fragrance ingredient used to add scent or mask odors. It is on the list of 26 fragrance allergens that the FDA, citing European Commission research, identifies as among those that most commonly cause allergic reactions from cosmetic products.

How Do I Find Class Action Settlements?

Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:

Sources

• Class action complaint, Mills v. Conopco, Inc., No. 3:26-cv-04286-SK (N.D. Cal. filed May 8, 2026) — Complaint PDF
• U.S. Food & Drug Administration, Hypoallergenic Cosmetics
• U.S. Food & Drug Administration, Allergens in Cosmetics

About This Lawsuit

This is an active, early-stage class action lawsuit. There is no settlement, no claim form, and no money available at this time. If the case results in a settlement or verdict, eligible consumers will be notified through the court system. OpenClassActions.com will update this page as the case progresses. OpenClassActions.com is a consumer advocacy and class action news site, and is not a class action administrator or a law firm.

For more class actions keep scrolling below.

Status Complaint Filed — Early Stage (No Settlement)

Case Title Mills v. Conopco, Inc.

Case Number 3:26-cv-04286-SK

Court U.S. District Court, Northern District of California

Date Filed May 8, 2026

Defendant Conopco, Inc. (a Unilever subsidiary)

Product Dove Sensitive Hypoallergenic Body Wash

Proposed Class California and nationwide buyers of the product during the applicable class period

Claims Breach of express warranty; UCL; False Advertising Law; CLRA; unjust enrichment

Damages Sought Restitution/disgorgement, damages, penalties, injunctive relief, fees; jury demanded